Tuesday, 5 November 2024 at 11.00 – 12.00 CET
In connection with the publication of Coloplast’s interim financial results for FY 2023/24 the company will host a conference call to present the financial results and answer questions from investors and financial analysts.
A presentation will be available on Coloplast’s website approximately 1 hour before the conference call.
Please note that the webcast of the conference call will be available during and after the event.
Coloplast will be represented by:
Kristian Villumsen – President & CEO
Anders Lonning-Skovgaard – Executive Vice President, CFO
Aleksandra Dimovska – Vice President, Investor Relations
Kristine Husted Munk – Senior Manager, Investor Relations
Webcast
Any participants who do not wish to actively participate in the question & answer session, please access the conference call as a webcast directly by clicking here:
Dial-in details
For analysts and any participants wishing to actively participate in the question & answer session please sign up ahead of the conference call on the link below to receive an email with dial-in details:
For more information, please contact:
Aleksandra Dimovska, Vice President, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 2458, e-mail: [email protected]
Kristine Husted Munk, Senior Manager, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 3266, e-mail: [email protected]
Julie Sommer Müggler, Coordinator & PA, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 3161, e-mail: [email protected]
Konstancija Norvilaite, Associate IR & Finance Manager, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 2803, e-mail: [email protected]
Coloplast will be available on individual phone lines after the conference call for further questions.
Attachment
Invitation for Coloplasts FY 2023-24 conference call on 5 November 2024
